Onconic Therapeutics Inc. (KOSDAQ:476060)
14,220
-650 (-4.37%)
Oct 12, 2026, 3:30 PM KST
| Market Cap | 645.70B -31.3% |
| Revenue (ttm) | 82.17B +179.3% |
| Net Income | 24.25B +430.5% |
| EPS | 528.52 +375.6% |
| Shares Out | 45.41M |
| PE Ratio | 26.91 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 146,304 |
| Open | 14,920 |
| Previous Close | 14,870 |
| Day's Range | 14,220 - 15,170 |
| 52-Week Range | 8,790 - 28,900 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 6, 2026 |